Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

FD acquires QuantumKDB

12 Jan 2016 07:00

RNS Number : 5189L
First Derivatives PLC
12 January 2016
 

12 January 2016

 

First Derivatives plc

("FD", the "Company" or the "Group")

 

FD acquires QuantumKDB

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces that it has acquired the entire issued share capital of QuantumKDB (UK) Limited ("Quantum") for total consideration of up to £2.2m. The acquisition provides the Group with complementary consultancy expertise to support the growth of its Kx business and is expected to be earnings enhancing in the first full year following acquisition*.

 

Acquisition rationale

 

Quantum was founded in 2011 by its CEO Kieran Lucid and provides Kx consulting in the UK, US and Hong Kong. The majority of its clients operate in capital markets and the acquisition will strengthen the Group's relationship with certain key clients as well as adding to the existing customer base. Quantum has a total of 15 consultants with strong experience in Kx technology. In its latest financial year to 13 September 2015, Quantum reported profit before tax of £0.3m and had net assets of £0.25m at acquisition.

 

Terms of the Acquisition

 

The initial consideration for the acquisition is £1.7m of which £0.6m is payable in cash and £1.1m is payable through the issue of 72,940 new ordinary shares in FD (the "Consideration Shares"). Deferred consideration of up to £0.5m is payable on the achievement of certain targets on the 12 month anniversary of the acquisition.

 

Application has been made for the 72,940 Consideration Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 15 January 2016. The Consideration Shares will rank pari passu with the Company's existing ordinary shares in issue. Following this allotment, the total issued share capital of the Company will increase to 23,921,972 ordinary shares.

 

Kieran Lucid, Chief Executive Officer of Quantum, commented: "As the home of Kx technology, FD is a natural fit for us. We are joining at a time of rapid expansion in the Kx client base across industry sectors, as more and more clients appreciate the benefits of this technology that has dominated capital markets for more than 10 years. We are excited about drawing on the expertise we've gained to assist the Group in its ambitious plans for the future."

 

Brian Conlon, Chief Executive Officer of FD, commented: "We are experiencing increasing demand for Kx skills from existing and potential customers and the acquisition of Quantum will add to our existing capabilities and support our growth plans. We welcome its staff to the Group."

 

\* This statement does not constitute a profit forecast.

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc

(Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,500 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAEFFFELKEAF
Date   Source Headline
7th Mar 20167:00 amRNSEnterprise Securities Market Notice
1st Mar 20164:14 pmRNSIssue of Equity
29th Jan 20169:46 amRNSTotal Voting Rights
25th Jan 20167:00 amRNSEnterprise Securities Market Notice
22nd Jan 20163:31 pmRNSDirector/PDMR Shareholding
19th Jan 20163:28 pmRNSIssue of Equity
19th Jan 201611:16 amRNSDirector's Shareholding
19th Jan 201610:39 amRNSHolding(s) in Company
15th Jan 20167:00 amRNSEnterprise Securities Market Notice
14th Jan 20167:00 amRNSMOU with Utilismart
13th Jan 20163:25 pmRNSHolding(s) in Company
12th Jan 20167:00 amRNSFD acquires QuantumKDB
31st Dec 20157:00 amRNSTotal Voting Rights
7th Dec 20157:00 amRNSEnterprise Securities Market Notice
3rd Dec 20155:00 pmRNSHolding(s) in Company
1st Dec 20154:49 pmRNSIssue of Equity from exercise of Share Options
11th Nov 20157:00 amRNSHalf Yearly Report
2nd Nov 20157:00 amRNSContract win with National Stock Exchange of India
19th Oct 20157:00 amRNSNotice of Results and Trading Update
30th Sep 20151:33 pmRNSTotal Voting Rights
23rd Sep 20154:46 pmRNSIssue of Equity
16th Sep 20153:07 pmRNSHolding(s) in Company
10th Sep 20157:00 amRNSFormation of FD Labs
28th Aug 20157:00 amRNSTotal Voting Rights
6th Aug 20157:00 amRNSEnterprise Securities Market Notice
3rd Aug 20157:00 amRNSAppointment of Non-Executive Director
31st Jul 201511:22 amRNSIssue of Equity
31st Jul 201511:19 amRNSTotal Voting Rights
21st Jul 20153:22 pmRNSDirector/PDMR Shareholding
7th Jul 20155:31 pmRNSIssue of Equity from exercise of Share Options
25th Jun 20152:02 pmRNSResult of AGM
12th Jun 20155:15 pmRNSDirector's Shareholding
2nd Jun 20157:00 amRNSPreliminary Results
29th May 20154:59 pmRNSTotal Voting Rights
11th May 20157:00 amRNSChange of Adviser and Notice of Results
8th Apr 20157:00 amRNSEnterprise Securities Market Notice
1st Apr 201511:09 amRNSTotal Voting Rights
1st Apr 20157:00 amRNSFD acquires Affinity Systems for up to GBP7.7m
27th Mar 20157:00 amRNSEnterprise Securities Market Notice
24th Mar 20157:01 amRNSDirectorate Change and Appointment
24th Mar 20157:00 amRNSFD acquires ActivateClients Limited
19th Mar 20157:00 amRNSEnterprise Securities Market Notice
13th Mar 20154:29 pmRNSIssue of Equity
4th Mar 20157:00 amRNSEnterprise Securities Market Notice
4th Mar 20157:00 amRNSEnterprise Securities Market Notice
3rd Mar 20152:00 pmRNSFirst Derivatives strengthens board of Directors
3rd Mar 201511:06 amRNSResult of General Meeting
27th Feb 201511:27 amRNSTotal Voting Rights
26th Feb 20157:01 amRNSFD acquires Prelytix for up to USD20million
23rd Feb 20157:00 amRNSEnterprise Securities Market Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.